Todos Medical Ltd.

61 articles with Todos Medical Ltd.

• UPDATE:  Todos Medical Reports $2.0 Million in Revenue for the Third Quarter of 2020

  10/14/2020

  §   Received first payments from $47.5 million contract with Wisconsin client on October 9, 2020 §   Wisconsin client upped avg. kit purchases from 2,100+/day to 3,500+/day on October 12, 2020 §   Todos has completed equipment purchases for signed Q3/20 reagent supply agreements §   Existing contracts have the potential to deliver over $60 million in revenue to Todos by end Q2/2021 NEW YORK, NY, REHOVAT, ISRAEL, SINGAPORE, Oct. 14, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire   --  Todo

• Todos Medical Reports $2.0 Million in Revenue for the Third Quarter of 2020

  10/13/2020

  Received first payments from $47.5 million contract with Wisconsin client on October 9, 2020   Wisconsin client upped avg. kit purchases from 2,100+/day to 3,500+/day on October 12, 2020   Todos has completed equipment purchases for signed Q3/20 reagent supply agreements   Existing contracts that have the potential to deliver over $60 million in revenue to Todos by end Q2/2021 NEW YORK, NY, REHOVAT, ISRAEL, SINGAPORE, Oct. 13, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire   -- Todos Me

• Todos Medical Enters into Exclusive COVID-19 Testing Supply Agreement with MOTO+PARA’s National Mobile CLIA Lab Partner Integrated Health

  10/7/2020

  Todos Medical Ltd. announced that it has entered into an exclusive supply agreement with U.S. national mobile CLIA laboratory company Integrated Health LLC operating MOTOPARA Foundation’s mobile biosafety level 3-built laboratories developed to address the global COVID-19 pandemic.

• Todos Medical Enters into Exclusive Branding and Distribution Agreement with Melbourne Biotech for 96 and 384 Well RT-PCR Machines in the United States

  9/30/2020

  Todos Medical Ltd. (OTCQB: TOMDF) , an  in vitro  diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tests for the early detection of cancer and Alzheimer’s disease, today announced that it has entered into an exclusive branding and distribution agreement with Australia-headquartered Melbourne Biotech, a US FDA-reg

• Todos Medical Expands Existing Contract for COVID-19 PCR Testing Equipment & Supplies with Wisconsin-based Laboratory to $47.5 Million

  9/22/2020

  Todos Medical Ltd. announced that it has rapidly expanded its agreement with a Wisconsin-based laboratory to supply it with the necessary testing equipment and supplies to ramp up to 12,000 tests a day, for a total contract value of $47.5 million in reagent sales by Todos Medical over the next seven months.

• Todos Medical CEO Releases Letter to Shareholders

  9/18/2020

  Significant progress in establishing COVID-19 PCR-based diagnostic testing business in US 3CL Protease-based saliva test making progress in Israel 3CL Protease inhibitor NLC-001 dietary supplement added to commercial portfolio 2019 convertible note holders and institutional Q1/2020 convertible note holders sign temporary lock-up agreement NEW YORK, REHOVOT, Israel and SINGAPORE, Sept. 18, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Todos Medical Ltd. (OTCQB: TOMDF) , an  in vitro

• 3CL Protease Inhibitor NLC-001 Added to COVID-19-focused Joint Venture Between Todos Medical and NLC Pharma

  9/17/2020

  NLC-001 is a proprietary blend of plant extracts administered orally as dietary supplement   US FDA granted Certificate of Free Sale for NLC-001 on August 28, 2020   JV evaluating potential of NLC-001 to treat COVID-19 in clinical studies in Israel   Todos evaluating commercialization options for NLC-001 Worldwide

• Todos Medical Announces Commercial Launch of Todos Branded COVID-19 qPCR Test Kits in the United States

  9/11/2020

  Todos Medical Ltd. (OTCQB: TOMDF), an in vitro diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tests for the early detection of cancer and Alzheimer’s disease, today announced that the U.S. Food and Drug Administration (FDA) has added the  TODOS 2019-nCoV RT-qPCR Detection Kit to its Notified List under the Emergency Use Authorization program.

• Todos Medical Announces August Sales of $1,190,000, Up 100% Compared with July

  9/3/2020

  Todos Medical Ltd. (OTCQB: TOMDF) , an  in vitro  diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tests for the early detection of cancer and Alzheimer’s disease, today announced sales for the month of August 2020 were $1,190,000. This compares with sales for the month of July 2020 of $550,000, with growth driven by week

• Todos Medical Enters Into Partnership With Pangea for COVID-19 Testing and Contact Tracing

  9/2/2020

  Todos Medical Ltd. (OTCQB: TOMDF), an in vitro diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tests for the early detection of cancer and Alzheimer’s disease, today announced that it has entered into a COVID-19 testing and contract partnership with Pangea, based in Israel

• Todos Medical to Present at The LD 500 Virtual Conference

  8/31/2020

  Todos Medical Ltd. (OTCQB: TOMDF) , an  in vitro  diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tests for the early detection of cancer and Alzheimer’s disease, today announced that it will be presenting at the LD 500 investor conference on Thursday, September 3rd at 4:00 PM EST. Gerald Commissiong, President & CEO of Todos, will be presen

• Todos Medical Announces $23,760,000 Contract for COVID-19 PCR Testing Equipment & Supplies With Wisconsin-based Laboratory

  8/31/2020

  Todos Medical Ltd. (OTCQB: TOMDF) , an  in vitro  diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tests for the early detection of cancer and Alzheimer’s disease, today announced that it has entered into a sales agreement with a Wisconsin-based laboratory to supply it with the necessary testing equipment and supplies

• Todos Medical Appoints Marsha Fontanive as VP of Sales and Chris Gross as VP of Sales Operations

  8/25/2020

  Todos Medical Ltd. (OTCQB: TOMDF) , an  in vitro  diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tests for the early detection of cancer and Alzheimer’s disease, today announced that it has appointed Marsha Fontanive as Vice President of Sales, and Chris Gross as Vice President of Sales Operations. Collectively,

• Todos Medical Announces $1.2 Million Contract for COVID-19 PCR Testing Equipment & Supplies with Texas-based Laboratory

  8/24/2020

  Todos Medical Ltd. (OTCQB: TOMDF) , an  in vitro  diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tests for the early detection of cancer and Alzheimer’s disease, today announced that it has entered into a sales agreement with a Texas-based laboratory to supply it with the necessary testing equipment and supplies for

• Todos Medical Announces $6,000,000 Contract for COVID-19 PCR Testing Equipment & Supplies with New York-based Laboratory

  8/21/2020

  6-month contract anticipates demand of 3,000 tests per day   Todos has the right to supply up to 30,000 tests per day if demand increases for the lab NEW YORK, NY, REHOVOT, Israel, and SINGAPORE, Aug. 21, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Todos Medical Ltd. (OTCQB: TOMDF) , an  in vitro  diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tests for the early detection of cancer and Alzheimer’s disease,

• Todos Medical Announces Positive Proof-of-Concept Data for Novel 10-Minute Point-of-Care Saliva-based Test Detecting Active SARS-CoV-2 Infection

  8/17/2020

  Achieves analytical performance for detecting active 3C-protease in a rapid visual format   Initiates multicenter clinical trial at Assuta Ashdod Hospital and Tel Aviv University in Israel   Technology opens potential for self-administered tests at home, school, work and airports

• Todos Medical Acquires Distribution Rights to SARS-CoV-2 Rapid Point-of-Care Antigen Test and Rapid Point-of-Care PCR Test

  8/14/2020

  Todos Medical Ltd. (OTCQB: TOMDF) , an  in vitro  diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tests for the early detection of cancer and Alzheimer’s disease, today announced that it has entered into an agreement with a South Korean manufacturer of rapid diagnostic tests, for U.S. distribution rights to its propr

• UPDATE: Todos Medical Announces Common Stock Purchase Agreement with Lincoln Park Capital Fund, LLC

  8/10/2020

  Initial Investment of $275,000 followed by up to $10 Million commitment over 24-months

• Todos Medical Announces July Sales of COVID-19 Tests

  8/7/2020

   Todos Medical Ltd. (OTCQB: TOMDF), an  in vitro  diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tests for the early detection of cancer and Alzheimer’s disease, today announced sales of more than $550,000 for the month of July. Sales were driven by 3D Med ANDis auto-extraction ma

• Todos Medical Announces Common Stock Purchase Agreement with Lincoln Park Capital Fund, LLC

  8/6/2020

  Initial Investment of $275,000 followed by up to $10 Million commitment over 24-months REHOVOT, Israel, SINGAPORE and NEW YORK, NY, Aug. 06, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Todos Medical Ltd. (OTCQB: TOMDF) , an  in vitro  diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tests for the early detection of cancer and Alzheimer’s disease, today announced that it has entered into a purchase agreement and r